Reactive oxygen species (ROS) are an unavoidable byproduct of aerobic metabolism and a double-edged sword for complex cellular systems 1 . Although central to many disease states, ROS also function as second messengers during embryonic development and, in macrophages, contribute to host defense against infection 2,3 . Viral infections frequently induce ROS generation, either by stimulating host immune responses or by direct tissue injury 4 . HCV, a hepatotropic RNA virus with a unique capacity for persistence 5 , induces substantial intrahepatic oxidative stress, thereby promoting liver injury 6, 7 . Limited data suggest that lipid peroxidation restricts HCV replication 8 , but how it impairs the viral replicative machinery is unknown.
Reactive oxygen species (ROS) are an unavoidable byproduct of aerobic metabolism and a double-edged sword for complex cellular systems 1 . Although central to many disease states, ROS also function as second messengers during embryonic development and, in macrophages, contribute to host defense against infection 2,3 . Viral infections frequently induce ROS generation, either by stimulating host immune responses or by direct tissue injury 4 . HCV, a hepatotropic RNA virus with a unique capacity for persistence 5 , induces substantial intrahepatic oxidative stress, thereby promoting liver injury 6, 7 . Limited data suggest that lipid peroxidation restricts HCV replication 8 , but how it impairs the viral replicative machinery is unknown.
Although HCV is a leading cause of cirrhosis and liver cancer 5 , many details of its replication remain obscure, as most HCV strains replicate poorly in cell culture. A notable exception is JFH1, a genotype 2a virus recovered from a patient with fulminant hepatitis 9 . JFH1 recapitulates the entire virus life cycle and replicates efficiently in Huh-7 hepatoma cells [9] [10] [11] . In recent years, it has become a laboratory standard used in most studies of HCV replication. However, there is very limited understanding of the robust replication phenotype that sets it apart from other HCVs 12, 13 .
Like all positive-strand RNA virus genomes, the HCV genome is synthesized by a multiprotein replicase complex that assembles in association with intracellular membranes. Known as the 'membranous web' in HCV-infected cells 14, 15 , this specialized cytoplasmic compartment provides a platform for viral RNA synthesis. Its membranes are enriched in cholesterol, sphingolipids and phosphatidylinositol-4-phosphate 16, 17 . Assembly of the membranous web involves recruitment of phosphatidylinositol-4-phosphate-3 kinase and annexin A2 (refs. 17-19) and possibly also direct membrane remodeling by nonstructural HCV proteins 20 . Whereas lipid metabolism also plays key roles in later steps in the virus life cycle 21 , these modifications of intracellular membranes are closely linked to viral RNA synthesis.
Sphingolipids are increased in abundance within the replicase membranes and are important factors in HCV replication [22] [23] [24] [25] . Sphingomyelin interacts with and in some genotypes stimulates NS5B, the viral RNA-dependent RNA polymerase 23, 26 . While studying a r t i c l e s 9 2 8 VOLUME 20 | NUMBER 8 | AUGUST 2014 nature medicine these virus-host interactions in cell culture, we discovered that JFH1 differs from other HCV strains in its response to inhibitors of sphingolipid-converting enzymes. These initial observations led to experiments that show the HCV replicase to be exquisitely sensitive to endogenous lipid peroxidation, a feature lacking in the atypical JFH1 strain and other pathogenic RNA viruses. Our findings suggest that HCV possesses a unique capacity to sense lipid peroxides induced by infection and to respond to their presence by restricting viral RNA synthesis, thereby limiting virus replication and possibly facilitating virus persistence.
RESULTS

Sphingosine kinase-2 regulates HCV replication
We determined how inhibitors of sphingolipid-converting enzymes influence replication of three cell culture-adapted HCVs: H77S.3, a genotype 1a virus, N2, a genotype 1b virus, and HJ3-5, an intergenotypic chimera expressing the genotype 2a JFH1 replicase.
To assess replication, we monitored Gaussia princeps luciferase (GLuc) produced by Huh-7.5 cells transfected with synthetic viral RNAs containing in-frame GLuc insertions 27 ( Fig. 1a) . Unexpectedly, the H77S.3/GLuc and HJ3-5/GLuc RNAs demonstrated contrary responses to many inhibitors, including, most notably, SKI, a sphingosine kinase (SPHK) inhibitor ( Fig. 1b and Supplementary  Fig. 1a,b) . We also observed contrasting responses to sphingolipid supplementation ( Supplementary Fig. 1c ). SKI (1 µM) enhanced replication of H77S.3/GLuc and also N.2/GLuc by three-to sixfold but suppressed replication of HJ3-5/GLuc (Fig. 1b,c) . These effects were evident within 48 h of exposure. We observed similar effects with viral RNAs lacking GLuc insertions: SKI enhanced H77S.3 protein expression tenfold while slightly suppressing HJ3-5 protein expression (Fig. 1d) . Thus, changes in the cellular environment induced by SKI favor H77S.3 and N.2 replication and inhibit that of HJ3-5. These effects were not due to altered cell proliferation or viral RNA translation ( Supplementary Fig. 2a,b) . We observed similar results with autonomously replicating, subgenomic HCV RNAs ('replicons') in multiple cell types ( Supplementary Fig. 2c,d ). SPHK is expressed as two isoforms 28 , which we individually silenced by transfecting cells with gene-specific siRNAs. Partial type 2 SPHK (SPHK2) depletion enhanced replication of H77S.3/GLuc and N.2/GLuc, whereas SPHK1 depletion inhibited both viruses (Fig. 1e,f) . In contrast, replication of HJ3-5/GLuc and cell culture-adapted JFH1 (JFH-QL/GLuc, Fig. 1a ) viruses was increased following SPHK1 depletion and decreased after SPHK2 knockdown. Neither SPHK1 nor SPHK2 knockdown substantially affected cell proliferation (Supplementary Fig. 2e) . Thus, SKI enhances replication of H77S.3/ GLuc and N.2/GLuc by inhibiting SPHK2. Consistent with this, SKI preferentially inhibited SPHK2 in cell-free assays ( Supplementary  Fig. 2f ) and demonstrated no activity against endogenous SPHK1 at low concentrations (≤2 µM) (Supplementary Fig. 2g ). SKI did not act by regulating the intracellular abundance of sphingomyelin, cholesterol, triglyceride or lipid droplets, and sensitivity to SKI was not determined by the sphingomyelin binding domain of NS5B (Supplementary Results and Supplementary Figs. 3 and 4) .
Lipid peroxidation is a key factor in SKI regulation of HCV Polyunsaturated fatty acids (PUFAs) inhibit replication of genotype 1b HCV replicons by inducing lipid peroxidation 8, 29 . Notably, although PUFAs such as arachidonic acid, docosahexaenoic acid or linoleic acid potently suppressed H77S.3/GLuc replication without affecting cell viability, HJ3-5/GLuc was highly resistant to this inhibitory effect (Fig. 2a,b and Supplementary Fig. 5a,b) . Thus, PUFAs appear to phenocopy the effect of SPHK2 on HCV replication, suggesting that SPHK2 promotes lipid peroxidation. Consistent with this hypothesis, SKI completely abolished the inhibitory effects of PUFAs on H77S.3/GLuc and N.2/GLuc (Fig. 2c) . SKI also lowered the intracellular abundance of malondialdehyde (MDA), a secondary product GLuc   p7 2A  C E1 E2  NS2 NS3  4B 5A  5B   4A   p7 2A  C E1 E2  NS2 NS3  4B 5A  5B   4A   p7 2A  C E1 E2  NS2 NS3  4B 5A  5B   4A   p7 2A  C E1 E2  NS2 NS3  4B 5A  5B   4A   5′   5′ npg of peroxidative degradation, in both HCV-infected and uninfected cells (Fig. 2d) . SKI was as effective as the lipophilic antioxidants vitamin E (α-tocopherol) and coenzyme Q10 (CoQ10) in reducing MDA abundance and, like vitamin E and CoQ10, prevented large increases in lipid peroxidation induced by PUFAs (Fig. 2d,e) . SKI also reduced both endogenous and PUFA-induced synthesis of 8-isoprostane, an alternative biomarker of lipid peroxidation (Fig. 2e) . Conversely, RNAi-mediated depletion of SPHK1 increased the intracellular abundance of MDA in cells treated with increasing concentrations of linoleic acid, whereas SPHK2 knockdown, like SKI, reduced it (Fig. 2f) . Thus, the contrasting effects of SPHK1 and SPHK2 on HCV replication may be explained by their opposing actions on peroxidation of endogenous PUFA. These results identify SPHK2 as a key mediator of lipid peroxidation. Lipid-soluble antioxidants, including multiple forms of vitamin E (α-, rac-β-and γ-tocopherols), CoQ10 and butylated hydroxytoluene, enhanced H77S.3/GLuc replication in a concentration-dependent fashion, as described for a genotype 1b replicon 8 , but suppressed HJ3-5/GLuc replication ( Fig. 2g and Supplementary Fig. 5c-e) . Notably, the effects of vitamin E and SKI on H77S.3/GLuc or N.2/GLuc replication were not additive ( Fig. 2g and Supplementary Fig. 5f ), suggesting Fig. 5g ), whereas cumene hydroperoxide (CHP), a lipophilic oxidant, suppressed H77S.3/GLuc replication in a vitamin E-reversible fashion (Fig. 2h) . FBS contains substantial quantities of lipophilic antioxidants 8 . H77S.3/GLuc replication was 20-fold lower in FBS-free cultures but was enhanced 100-fold with either SKI or vitamin E (Fig. 2i) . HJ3-5/GLuc replication was relatively unimpaired in FBS-free medium. Collectively, these data provide evidence that endogenous lipid peroxidation restricts H77S.3/GLuc and N.2/GLuc replication, whereas the JFH1 replicase is resistant to both endogenous and chemically induced lipid peroxidation.
Endogenous lipid peroxidation restricts infectious HCV yield
Both SKI and vitamin E induced a tenfold increase in the yield of infectious virus released by H77S.3 RNA-transfected cells, reaching ~20,000 focus-forming units per milliliter (FFU ml −1 ) ( Fig. 3a and Supplementary Fig. 6a ). Infectious N.2 virus yields were increased up to 100-fold (Fig. 3a) . SKI also enhanced virus spread when we cultured H77S.3 RNA-transfected cells with nontransfected carboxyfluorescein succinimidyl ester (CFSE)-labeled cells (Fig. 3b) . In contrast, neither SKI nor vitamin E enhanced infectious yields of JFH1-QL or HJ3-5 viruses ( Fig. 3a) , whereas SKI reduced the spread of HJ3-5 virus by >40% (Fig. 3b) .
HCV particles produced in cell culture have heterogeneous buoyant densities 30 . However, most H77S.3 particles produced in the absence of SKI or vitamin E banded between 1.12 and 1.14 g cm −3 in isopycnic gradients, with peak infectivity banding between 1.10 and 1.11 g cm −3 (Fig. 3c) . Neither SKI nor vitamin E altered the distribution of RNA-containing or infectious particles in gradients, but they substantially increased the abundance of both (Fig. 3c) . SKI and vitamin E also caused modest increases in the maximum specific infectivity of virus particles (Supplementary Fig. 6b ). Thus, SKI and vitamin E act primarily on replication of H77S.3 RNA, leading to enhanced production of infectious virus.
Lipid peroxidation restricts HCV in primary hepatocytes
To assess replication of wild-type HCV genomes possessing no cell culture-adaptive mutations, we inserted a GLuc sequence into infectious molecular clones of H77c and N 31, 32 . Both H77c/GLuc and N/GLuc RNAs produced more GLuc in electroporated cells than RNA with a lethal mutation in NS5B, H77c/GLuc-AAG (Fig. 4a) . GLuc secretion produced by either RNA was eliminated by direct-acting antivirals (DAA) targeting NS5B, confirming it represents genuine viral replication. Treatment with either SKI or vitamin E markedly increased GLuc production, whereas linoleic acid decreased GLuc secretion to background (Fig. 4a) . Moreover, the inhibitory effect of linoleic acid was reversed by cotreatment with SKI or vitamin E. In contrast, GLuc production by wild-type JFH1/GLuc was not affected by SKI, vitamin E or linoleic acid (Fig. 4b) . Thus, endogenous lipid peroxidation is a critical restriction factor for H77c and N viruses but not for wild-type JFH1.
To assess the effects of SKI and vitamin E on HCV replication in cells that are closely related to those naturally infected by the virus, we studied primary human fetal hepatoblasts (HFHs). SKI and vitamin E significantly increased replication of the H77S.3/GLuc reporter virus in HFHs (P < 0.0001 by two-way analysis of variance (ANOVA) with Holm-Sidak correction for multiple comparisons), sustaining GLuc expression for 7 d after low-multiplicity infection (Fig. 4c,d ). In contrast, linoleic acid suppressed H77S.3 infection in HFHs in a vitamin Ereversible manner (Fig. 4d) . Whereas H77S.3/GLuc replicated efficiently in the presence of vitamin E or SKI, HJ3-5/GLuc replication was inhibited by SKI (P < 0.001 by two-way ANOVA with Holm-Sidak correction for multiple comparisons) and to a lesser extent by vitamin E 
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(P < 0.05) (Fig. 4d) . We observed similar results in cells infected with H77S.3 or HJ3-5 viruses lacking a GLuc insertion (Fig. 4e) . We detected production of infectious H77S.3 virus in HFH cultures only in the presence of vitamin E or SKI and found that infectious HJ3-5 yields were not enhanced by either treatment (Fig. 4f) . Whereas the disruption of innate immune responses is known to promote HCV replication in HFHs 33 , neither SKI nor vitamin E reduced Sendai virus activation of the interferon-β promoter (Supplementary Fig. 7 ). Thus, SKI and vitamin E do not promote H77S.3 replication in HFHs by blocking activation of the interferon response to virus infection.
Lipid peroxidation reduces the EC 50 of direct antivirals Both SKI and vitamin E treatment increased the area occupied by the membranous web in H77S.3-infected cells (Fig. 5a,b) without altering the morphology of double-membrane vesicles, which are the likely site of genome replication 14 . Increased lipid peroxidation reduced the area occupied by the membranous web, whereas the HJ3-5 membranous web was insensitive to changes in lipid peroxidation. Reverse molecular genetic studies involving exchanges between the H77S.3 and JFH1 genomes suggested that the peroxidation resistance phenotype of JFH1 involves multiple nonstructural proteins within the replicase (Supplementary Results and Supplementary Fig. 8) . Consistent with this, we observed an unexpected increase in the 50% effective concentration (EC 50 ) of DAAs targeting the NS3-4A protease (a noncovalent complex of NS3 and its cofactor, NS4A) and NS5B polymerase after suppressing endogenous lipid peroxidation in H77S.3/GLuc-infected cells (Fig. 5d,e and Supplementary Fig. 9a-c) . Both SKI and vitamin E masked the antiviral effects of PSI-6130, a potent NS5B inhibitor (Fig. 5c) , in part owing to an increase in its EC 50 from 3.49 µM (95% confidence interval (CI) 2.48-4.89) to 6.22 µM (4. 43-8.72 ) and 8.46 µM (7.60-9.44), respectively (Fig. 5d) . SKI and vitamin E also increased the EC 50 of MK-7009, an inhibitor of the NS3-4A protease, from 0.488 nM (95% CI 0.411-0.578) to 1.45 nM (1.23-1.72) and 1.90 nM (1.64-2.22), respectively (Fig. 5e) . The EC 50 values of other inhibitors targeting NS3-4A (boceprevir) and NS5B (HCV-796 and MK-0608) were similarly increased against H77S.3/GLuc by SKI and vitamin E, but neither SKI nor vitamin E significantly altered the EC 50 of SCY-635, cyclosporine A, compound 23 or a locked nucleic acid-modified oligonucleotide complementary to miR-122 (anti-miR-122), inhibitors targeting essential HCV host factors, or interferon-α (Fig. 5f,g and Supplementary Fig. 9d-g ). In contrast, SKI and vitamin E caused no change in the EC 50 of any antiviral against HJ3-5/GLuc (Fig. 5d,g and Supplementary Fig. 9a-f) , indicating that vitamin E and SKI do not impair cellular uptake or metabolism of DAAs. These changes in the EC 50 against H77S.3/GLuc thus probably reflect altered affinity of the DAAs for NS3-4A and NS5B, suggesting that peroxidation modulates the conformation of these replicase proteins.
Resistance to lipid peroxidation maps to NS4A and NS5B TNcc is a recently described genotype 1a virus with eight cell cultureadaptive mutations that replicates almost as well as JFH1 in Huh-7.5 cells 34 . Notably, we found it completely resistant to lipid peroxidation ( Fig. 6a and Supplementary Fig. 10a ). We introduced all eight TNcc mutations into H77S.3 to determine whether they would confer peroxidation resistance. This RNA (H77S.3/GLuc 8mt ) failed to replicate, but removal of a key H77S.3 adaptive mutation (S2204I in NS5A) 12 restored low-level replication. The resulting virus, H77S.3/GLuc IS/8mt , was resistant to lipid peroxidation ( Fig. 6a and  Supplementary Fig. 10b ). Continued passage of cells infected with H77S.3 IS/8mt resulted in the emergence of viruses carrying additional mutations in NS4B (G1909S), NS5A (D2416G) and NS5B (G2963D) that together enhanced replication by 850-fold (Supplementary  Results and Supplementary Fig. 11 ). The NS4B G1909S mutation npg compensated for the negative effects on replication of TNcc mutations placed into the H77S.3 background (Fig. 6b) . When we introduced all three additional mutations (G1909S, D2416G and G2963D) into H77S.3/GLuc IS/8mt , the resulting virus (designated H77D) produced infectious virus yields comparable to those of HJ3-5 or JFH1-QL, which were not increased by vitamin E supplementation (Fig. 6b) . Notably, the EC 50 of DAAs against H77D virus was not altered by SKI or vitamin E ( Fig. 6d and Supplementary Fig. 9h ).
Introducing the G1909S mutation into H77S.3/GLuc IS (H77S.3/ GLuc IS/GS ) did not confer peroxidation resistance (Fig. 6a) . However, its compensatory effect on the TNcc-derived mutations allowed us to identify the A1672S mutation (in NS4A) from TNcc as essential for peroxidation resistance and to show that TNcc-derived mutations in NS3 and NS4B were not required for this phenotype (Fig. 6a) . TNcc mutations in NS5B (D2979G, Y2981F and F2994S) were essential for replication of peroxidation-resistant virus, but neither these nor A1672S (in NS4A) alone conferred peroxidation resistance (Supplementary Fig. 10c ). Thus, mutations in both NS4A and NS5B are required for genotype 1a peroxidation resistance. These mutations are within or in close proximity to the transmembrane domains of these proteins (Fig. 6c) , consistent with direct involvement of these residues in resistance to lipid peroxidation.
Regulation by lipid peroxidation is unique to HCV In addition to replication of genotypes 1a (H77S.3) and 1b (HCV-N.2) (Figs. 2c and 3a) , replication of HCV genotypes 2a (JFH-2), 3a (S52) and 4a (ED43) was enhanced by treatment with SKI or vitamin E and inhibited by CHP-induced lipid peroxidation (Fig. 6e) . JFH1 is thus unique among wild-type HCV strains in its resistance to lipid peroxidation.
As with HCV, the genomes of other positive-strand RNA viruses are synthesized by replicase complexes that assemble in association with cytoplasmic membranes and are thus at risk for damage due to lipid peroxidation. Yet, like replication of JFH1, the replication of other npg pathogenic positive-strand RNA viruses, including flaviviruses, picornaviruses and alphaviruses, is neither enhanced by SKI or vitamin E nor suppressed by linoleic acid (Fig. 6f and Supplementary Fig. 12a-c) . This is also true for clone 13 lymphocytic choriomeningitis virus, an ambisense RNA virus that establishes persistent infections ( Fig. 6f and Supplementary Fig. 12d ). Thus, most viral RNA replicases have evolved in ways that prevent or mitigate the potentially negative effects of lipid peroxidation. HCV is a clear exception, suggesting that its sensitivity to lipid peroxidation may provide a distinct survival advantage.
DISCUSSION
Lipid peroxides are formed on polyunsaturated fatty acid chains within membranes by reactive intermediates produced during oxidative stress. They alter membrane fluidity and permeability and potentially contribute to a variety of disease states 35 . The degradation products of these lipid peroxides include reactive aldehydes, such as acrolein, 4-hydroxy-2-nonenal and MDA, that add to this damage by forming adducts with membrane proteins, thereby modulating their biological activities 35, 36 . To our knowledge, the opposing effects of SPHK1 and SPHK2 on lipid peroxidation that we observed (yellow arrowheads) that confer resistance to lipid peroxidation when introduced into H77S.3/GLuc IS (H77S.3/GLuc, in which the adaptive mutation S2204I has been removed (black arrowheads); details are shown in Supplementary Fig. 10b ). GLuc produced from Huh-7.5 cells transfected with indicated RNAs and treated with DMSO, 1 µM SKI, 1 µM vitamin E, 10 µM CHP, CHP plus vitamin E or 30 µM sofosbuvir (DAA). GLuc secreted between 48-72 h is shown. Bottom, role played by TNcc mutations in NS3 (helicase) and NS4B in resistance to lipid peroxidation. Combinations of TNcc substitutions were introduced into H77S.3/GLuc IS/GS (NS proteins shown only) that contains the compensatory mutation G1909S (GS) in NS4B (red arrowhead, Supplementary Fig. 11 ). Data represent mean GLuc activity ± s.e.m. from two independent experiments. (b) Top, H77D genome containing the I2204S substitution (black arrowhead), eight TNcc-derived mutations (yellow arrowheads) and three additional compensatory mutations (red arrowheads) in the H77S. have not been noted previously; they remain unexplained. SPHK1 is predominantly cytosolic and translocates to the plasma membrane upon activation 37 , whereas SPHK2 is more likely to be associated with intracellular membranes 28 . Sphingosine-1-phosphate produced by SPHK functions as a messenger in several signaling pathways and is a cofactor for enzymes involved in signal transduction and transcriptional regulation 38, 39 . However, it has no effect on HCV replication in cell cultures and only minimally increases MDA abundance (Supplementary Fig. 1c,d) . During HCV infection, oxidative stress is caused by both host inflammatory responses and direct interactions of viral proteins with mitochondria 7, 40 . Our results show that the wild-type H77c and N replicases are highly sensitive to both endogenous and PUFA-induced lipid peroxidation. Con1 and OR6, two other genotype 1 HCVs, are also inhibited by PUFA-induced peroxidation 8, 41 . Given that we found that lipid peroxidation also inhibits multiple other HCV genotypes, we conclude that this sensitivity to peroxidation is a common feature of HCV.
In genotype 1a H77S.3 virus, we found that resistance to lipid peroxidation maps to residues within or near the transmembrane domains of NS4A and NS5B, key components of the replicase complex. Reactive aldehydes derived from degraded lipid peroxides could form adducts with residues within these transmembrane domains, impairing their capacity for essential interactions and thereby reducing replicase activity. The A1672S mutation promotes oligodimerization of the NS4A transmembrane domain, an interaction necessary for efficient replicase function 42 . Thus, A1672S might confer resistance to peroxidation by restoring NS4A dimerization impaired by adduct formation. Adduct formation could similarly affect the NS5B transmembrane domain. Although hypothetical, such effects could explain the changes we observed in the EC 50 of DAAs targeting NS3-4A and NS5B. Alternatively, proper membrane localization and assembly of nonstructural proteins within the replicase may require lipids esterified with nonoxidized fatty acid chains. Indeed, we found that monounsaturated fatty acid supplements such as oleic acid stimulate H77S.3/ GLuc and N.2/GLuc replication but not that of JFH1 ( Supplementary  Fig. 5h) . A third possibility is that lipid peroxidation could induce changes in membrane fluidity that alter replicase conformation 35 .
We propose that HCV exploits lipid peroxidation as a means of autoregulating its replication and that lipid peroxides act as a brake, downregulating the efficiency of genome amplification when reaching a threshold abundance (Supplementary Fig. 13 ). Such a model suggests that HCV possesses a conserved peroxidation 'sensor' , mapping in part to the transmembrane domains of NS4A and NS5B, that governs replication efficiency, thereby limiting tissue damage, reducing viral exposure to the immune system and facilitating viral persistence. Although hepatotoxicity associated with diets deficient in lipophilic antioxidants presents a technical barrier to testing this hypothesis in murine models of HCV 43 , our results show that in primary human hepatocytes, HCV replication is regulated by lipid peroxidation. Related RNA viruses that are capable of establishing persistent infection appear to autorestrict replication via alternative mechanisms. For example, bovine viral diarrhea virus, a pestivirus that establishes lifelong persistence, downregulates replicase formation by limiting cleavage of its NS2-3 protein, thereby arresting RNA synthesis and enabling a noncytolytic phenotype 44 . Thus, reducing the efficiency of the replicase may be a common theme for RNA viruses that establish persistent infection.
Like most other positive-strand RNA viruses, the genotype 2a JFH1 virus is highly resistant to lipid peroxidation. This suggests that JFH1 may be a loss-of-function mutant that no longer senses lipid peroxides and autorestricts its replicase activity. Whether the original JFH1 patient isolate similarly lacked the ability to be regulated by lipid peroxidation is uncertain, as is the possibility that lack of peroxidation sensitivity contributed in some way to the fulminant hepatitis experienced by this patient 9 . Only one of the four amino acid substitutions conferring peroxidation resistance in H77S.3 (NS5B F2981) exists in JFH1, and the molecular basis of its peroxidation resistance remains to be determined. Nonetheless, our results provide a basis for understanding the robust capacity of the JFH1 virus to replicate in cell culture. Our findings also highlight the uniqueness of HCV regulation by lipid peroxidation among other pathogenic RNA viruses and its potential importance to the pathogenesis of chronic hepatitis C.
METHODS
Methods and any associated references are available in the online version of the paper. gradient in Hank's balanced salt solution (HBSS, Invitrogen). Gradients were centrifuged in a SureSpin 630 Swinging Bucket Rotor (Thermo Scientific) at 30,000 r.p.m. for 24 h at 4 °C, and fractions were collected from the top of the tube. The density of each fraction was calculated from the refractive index measured with a refractometer (ATAGO). RNA was isolated from each fraction using QIAamp Viral RNA kit (Qiagen) and the viral amount quantified by qRT-PCR as described below. Infectious virus titers in each fraction were determined as described above.
qRT-PCR. One-step qRT-PCR analysis of HCV RNA in Huh-7.5 cells was carried out as described 52 . HCV RNA in primary human fetal hepatoblast cultures was detected by means of a two-step qRT-PCR procedure using SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen), followed by TaqMan qPCR analysis with primer pairs and a probe targeting a conserved 221-base sequence within the 5′ UTR of the genome and iQ Supermix (Bio-Rad) 52 .
RNA interference. Validated siRNA targeting human SPHK1 (SI02660455) 57 was purchased from Qiagen. siRNA targeting human SPHK2 (5′-CGUCAC GGUUAAAGAGAAA-3′) 39 and control siRNA (#2) were from Dharmacon. siRNA (20 nM) was transfected into cells using siLentfect Lipid Reagent (Bio-Rad) according to the manufacturer's protocol.
Immunoblots.
Immunoblotting was carried out using standard methods with the following antibodies: mouse monoclonal antibodies to β-actin (AC-74, Sigma, 1:10,000), HCV NS3 (ab65407, Abcam, 1:500) and rabbit polyclonal antibodies to SPHK1 (A302-177A, Bethyl Laboratories, 1:2,000) or SPHK2 (ab37977, Abcam, 1:500). Protein bands were visualized and quantified with an Odyssey Infrared Imaging System (Li-Cor Biosciences).
Sphingosine kinase assay. Sphingosine kinase activity was determined as described previously 28 . Recombinant human SPHK1 and SPHK2 proteins were obtained from BPS Bioscience. SPHK1 activity was determined in the presence of 0.25% Triton X-100, which inhibits SPHK2 (ref. Quantification of cholesterol and triglyceride levels. Cells were scraped and lysed in PBS containing 1% Triton X-100 and complete protease inhibitor cocktail (Roche). Cell lysates were clarified by centrifugation at 15,000 r.p.m. at 4 °C for 10 min. Cholesterol contents were determined using the Amplex Red Cholesterol Assay Kit (Invitrogen) according to the manufacturer's protocol. Triglyceride levels in cells grown on 96-well plates were determined using Triglyceride Assay Kit (Zen-Bio) as per manufacturer's instruction. The values were normalized to the total protein content.
Lipid peroxidation assays. Malondialdehyde (MDA), a product of lipid peroxidation, was quantified by the thiobarbituric acid reactive substances (TBARS) Assay Kit (Cayman Chemical). Cells transfected with HCV RNAs were grown in the presence of different drugs and analyzed for intracellular malondialdehyde (MDA) abundance at 48-72 h as indicated in legends. Cells scraped into PBS containing complete protease inhibitor cocktail (Roche) were homogenized by sonication on ice using Sonic Dismembrator (FB-120, Fisher Scientific). The amount of MDA in 100 µl of cell homogenates was analyzed by a fluorescent method as described by the manufacturer. Lipid peroxidation levels were expressed as the amount of MDA normalized to the amount of total protein. Alternatively, the lipid peroxidation product, 8-isoprostane, was quantified using the 8-Isoprostane EIA kit (Cayman Chemical) according to the manufacturer's recommended procedures.
Innate immune response reporter assays. IFN-β-, IRF-3-and NF-κB-dependent promoter activities were assayed using firefly luciferase reporters pIFN-β-Luc, p4xIRF3-Luc or pPRDII-Luc as described previously 58 . Cells were cotransfected with the reporter plasmid pRL-CMV, and the firefly luciferase results were normalized to Renilla luciferase activity in order to control for potential differences in transfection efficiency. The luminescence was measured on a Synergy 2 (BioTek) Multi-Mode Microplate Reader.
Mass spectrometry of sphingolipids and metabolites. Cells were washed extensively with PBS and scraped into tubes. An aliquot of cells was taken for protein and total lipid phosphate measurements. After addition of a sphingolipid internal standard cocktail (Avanti Polar Lipids), the lipids were extracted, and individual sphingolipid species were quantified by liquid chromatography, electrospray ionization-tandem mass spectrometry as described previously 59, 60 .
Electron microscopy. Huh-7.5 cells (5 × 10 6 cells) electroporated with 5 µg HCV RNA were seeded into a 6-well plate, and medium containing compounds was added 24 h later. At 48 h after transfection, cells were fixed with 3% glutaraldehyde in 0.15 M sodium phosphate buffer, pH 7.4, for 1 h at room temperature and stored at 4 °C until processed. Following three rinses with 0.15 M sodium phosphate buffer, pH 7.4, monolayers were postfixed with 1% osmium tetroxide for 1 h, washed in deionized water and stained en bloc with 2% aqueous uranyl acetate for 20 min. The cells were dehydrated using increasing concentrations of ethanol (30%, 50%, 75%, 100%, 100%, 10 min each) and embedded in Polybed 812 epoxy resin (Polysciences, Inc.). Cell layers were sectioned en face to the substrate at 70 nm using a diamond knife and a Leica Ultracut UCT microtome (Leica Microsystems). Ultrathin sections were mounted on 200 mesh copper grids and stained with 4% aqueous uranyl acetate and Reynolds' lead citrate 61 . The grids were observed at 80 kV using a LEO EM910 transmission electron microscope (Carl Zeiss SMT, LLC). Digital images were taken using a Gatan Orius SC 1000 CCD Camera with DigitalMicrograph 3.11.0 software (Gatan, Inc.). Step RT-PCR kit with SYBR green (Bio-Rad) and primer pairs as follows: HAV forward 5′-GGTAGGCTACGGGTGAAAC-3′ and reverse 5′-AACAACTCACCAATATCCGC-3′, RRV forward 5′-AGAGT GCGGAAGACCCAGAG-3′ and reverse 5′-CCGTGATCTTACCGGACA CA-3′, SINV forward 5′-GAGGTAGTAGCACAGCAGG-3′, and reverse 5′-CG GAAAACATTCTACGAGC-3′ and LCMV forward 5′-CATTCACCTGGACTTT GTCAGACTC-3′ and reverse 5′-GCAACTGCTGTGTTCCCGAAAC-3′. WNV and YFV RNA levels were quantified using a previously described method 62 with primers as follows: WNV forward 5′-TCAGCGATCTCTCCACCAAAG-3′ and reverse 5′-GGGTCAGCACGTTTGTCATTG-3′ and YFV forward 5′-CT GTCCCAATCTCAGTCC-3′ and reverse 5′-AATGCTCCCTTTCCCAAA TA-3′. DENV RNA was quantified on a 7900 HT Real-Time PCR System (ABI) using primers and probe as described 63 .
Peroxidation resistance of hepatitis
The infrared fluorescent immunofocus assay for infectious hepatitis A virus (HAV) was done using FRhK-4 cells as previously described 64 . Titration of infectious alphaviruses was performed in duplicate by visualization of plaques on Vero cells seeded in 12-well plates. Plates were incubated with inoculum at 37 °C with 5% CO 2 for 1 h with periodic agitation. Inocula were then removed and plates overlaid with 1.25% carboxymethylcellulose in MEM supplemented with 3% FBS, 1× penicillin-streptomycin, 2 mM l-glutamine and HEPES. All of these reagents were identical to those used for parallel studies of HCV. At 48 h after infection, plates were fixed with 4% paraformaldehyde and visualized with a 0.25% crystal violet solution. Infectious titers of WNV and YFV were determined by plaque assay on confluent BHK cell monolayers in 6-well plates. Cells were incubated with virus inocula for 2 h at 37 °C, washed before addition of a 1% methylcellulose medium overlay and further incubated for 3 d. Plaques were visualized with Giemsa staining. DENV titers were determined by plaque assay on Vero 76 cell monolayers in 96-well plates. Cells were incubated with virus inocula for 2 h at 37 °C, washed before addition of a 0.8% methylcellulose medium overlay and further incubated for 3 d. Following fixation with ice-cold acetone methanol solution (50:50 v/v), cells were immunostained using the DENV E-specific monoclonal antibody 4G2 (UNC Antibody Core Facility, 1:500) followed by HRP-conjugated anti-mouse IgG secondary antibody (KPL, 464-1806, 1:1,000). Infectious foci were visualized using Vector VIP reagent (Vector Labs). LCMV titers were determined by plaque assay on confluent Vero cell monolayers in 6-well plates 65 . Cells were incubated with virus inocula for 80 min at 37 °C before addition of a 1:1 mixture of 1% agarose and EMEM medium containing 10% FCS, 2 mM l-glutamine, 2% penicillin and npg
